Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces
cg.authorship.types | CGIAR and developing country institute | en |
cg.authorship.types | CGIAR and advanced research institute | en |
cg.contributor.affiliation | International Livestock Research Institute | en |
cg.contributor.affiliation | University of Liverpool | en |
cg.contributor.affiliation | Imperial College London | en |
cg.contributor.affiliation | Hammersmith Hospital | en |
cg.contributor.affiliation | Animal and Plant Health Agency, New Haw, United Kingdom | en |
cg.contributor.affiliation | University of KwaZulu-Natal | en |
cg.contributor.affiliation | United Kingdom Health Security Agency | en |
cg.contributor.affiliation | Newcastle University | en |
cg.contributor.affiliation | University of Ghana | en |
cg.contributor.affiliation | Wellcome Trust | en |
cg.contributor.affiliation | University of Cambridge | en |
cg.contributor.affiliation | Liverpool School of Tropical Medicine | en |
cg.contributor.affiliation | Malawi Liverpool Wellcome Research Programme | en |
cg.contributor.affiliation | University of Sydney | en |
cg.contributor.affiliation | University of Glasgow | en |
cg.contributor.donor | British Society for Antimicrobial Chemotherapy | en |
cg.contributor.donor | Wellcome Trust | en |
cg.contributor.donor | Illumina | en |
cg.contributor.donor | Bill & Melinda Gates Foundation | en |
cg.contributor.donor | United Kingdom Research and Innovation | en |
cg.contributor.donor | National Institute for Health Research, United Kingdom | en |
cg.contributor.donor | Biotechnology and Biological Sciences Research Council, United Kingdom | en |
cg.contributor.donor | Medical Research Council, United Kingdom | en |
cg.contributor.donor | United Kingdom Health Security Agency | en |
cg.contributor.donor | Rosetrees Trust | en |
cg.contributor.donor | Stoneygate Trust | en |
cg.creator.identifier | Dishon Muloi: 0000-0002-6236-2280 | |
cg.howPublished | Formally Published | en |
cg.identifier.doi | https://doi.org/10.1016/s2666-5247(23)00284-7 | en |
cg.isijournal | ISI Journal | en |
cg.issn | 2666-5247 | en |
cg.issue | 12 | en |
cg.journal | Lancet Microbe | en |
cg.reviewStatus | Peer Review | en |
cg.subject.actionArea | Resilient Agrifood Systems | |
cg.subject.ilri | AMR | en |
cg.subject.ilri | ONE HEALTH | en |
cg.subject.impactArea | Nutrition, health and food security | |
cg.subject.impactPlatform | Nutrition, Health and Food Security | |
cg.subject.sdg | SDG 3 - Good health and well-being | en |
cg.volume | 4 | en |
dc.contributor.author | Muloi, Dishon | en |
dc.contributor.author | Jauneikaite, E. | en |
dc.contributor.author | Anjum, M.F. | en |
dc.contributor.author | Essack, S.Y. | en |
dc.contributor.author | Singleton, D.A. | en |
dc.contributor.author | Kasudi, M.R. | en |
dc.contributor.author | Wade, M.J. | en |
dc.contributor.author | Egyir, B. | en |
dc.contributor.author | Nunn, J.G. | en |
dc.contributor.author | Midega, J.T. | en |
dc.contributor.author | Peacock, S.J. | en |
dc.contributor.author | Feasey, N.A. | en |
dc.contributor.author | Baker, K.S. | en |
dc.contributor.author | Zadoks, R.N. | en |
dc.contributor.author | SEDRIC Genomics Surveillance Working Group | en |
dc.date.accessioned | 2023-11-15T10:37:15Z | en |
dc.date.available | 2023-11-15T10:37:15Z | en |
dc.identifier.uri | https://hdl.handle.net/10568/134506 | |
dc.title | Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces | en |
dcterms.abstract | The intersection of human, animal, and ecosystem health at One Health interfaces is recognised as being of key importance in the evolution and spread of antimicrobial resistance (AMR) and represents an important, and yet rarely realised opportunity to undertake vital AMR surveillance. A working group of international experts in pathogen genomics, AMR, and One Health convened to take part in a workshop series and online consultation focused on the opportunities and challenges facing genomic AMR surveillance in a range of settings. Here we outline the working group's discussion of the potential utility, advantages of, and barriers to, the implementation of genomic AMR surveillance at One Health interfaces and propose a series of recommendations for addressing these challenges. Embedding AMR surveillance at One Health interfaces will require the development of clear beneficial use cases, especially in low-income and middle-income countries. Evidence of directionality, risks to human and animal health, and potential trade implications were also identified by the working group as key issues. Addressing these challenges will be vital to enable genomic surveillance technology to reach its full potential for assessing the risk of transmission of AMR between the environment, animals, and humans at One Health interfaces. This is the fourth in a Series of five papers about harnessing genomics for antimicrobial resistance surveillance. All papers in the Series are available at www.thelancet.com/microbe. | en |
dcterms.accessRights | Open Access | |
dcterms.audience | Academics | en |
dcterms.audience | Scientists | en |
dcterms.available | 2023-11-14 | |
dcterms.bibliographicCitation | Muloi, D.M., Jauneikaite, E., Anjum, M.F., Essack, S.Y., Singleton, D.A., Kasudi, M.R., Wade, M.J., Egyir, B., Nunn, J.G., Midega, J.T., Peacock, S.J., Feasey, N.A., Baker, K.S. and Zadoks, R.N. for the SEDRIC Genomics Surveillance Working Group. 2023. Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces. Lancet Microbe e1056–e1062. | en |
dcterms.extent | e1056–e1062 | en |
dcterms.issued | 2023-12 | |
dcterms.language | en | |
dcterms.license | CC-BY-4.0 | |
dcterms.publisher | Elsevier | en |
dcterms.subject | antimicrobial resistance | en |
dcterms.subject | genomics | en |
dcterms.subject | one health approach | en |
dcterms.type | Journal Article |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.75 KB
- Format:
- Item-specific license agreed upon to submission
- Description: